Literature DB >> 184881

Modulation in the sensitivity of noradrenergic receptors in the CNS studied by the responsiveness of the cyclic AMP system.

M Baudry, M P Martres, J C Schwartz.   

Abstract

Various characteristics of the altered responsiveness to noradrenaline (NA) of the cyclic Amp (cAMP) generating system of cortical brain slices have been studied in rat after chronic reserpine treatment and in mice after chronic D-amphetamine treatment. Supersensitivity of the cAMP system to NA following reserpine treatment and subsensitivity after D-amphetamine treatment exhibit many common features. Firstly, in both cases the modified responsiveness to NA occurs rapidly after the beginning of the treatment (one day for reserpine and 5 h after amphetamine) and recovers slowly after the end of the treatment. Additionally, the altered states of sensitivity of the cAMP system to NA are the result of a modification of the maximal response rather than of an altered affinity of the system to NA. Since, following D-amphetamine treatment the change of sensitivity is still apparent in the presence of a potent phosphodiesterase inhibitor, the involvement of a gross alteration of phosphodiesterase activity is unlikely. In this case too, while the response to adenosine is slightly decreased, the responses to dopamine and serotonin of the cAMP system observed in brain slices following D-amphetamine treatment is not detected in a cell-free preparation. Thus, it appears that drug treatments, modifying synaptic transmission in opposite directions, lead also to changes in opposite directions of the responsiveness of the cAMP system to NA. The hypothesis that the mechanisms underlying such phenomena are related to a modified number of functional noradrenergic receptors is discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 184881     DOI: 10.1016/0006-8993(76)90252-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

1.  Facilitation of self-stimulation of the prefrontal cortex in rats following chronic administration of spiroperidol or amphetamine.

Authors:  A Robertson; G J Mogenson
Journal:  Psychopharmacology (Berl)       Date:  1979-10       Impact factor: 4.530

2.  Modification of the noradrenergic cyclic AMP generating system in the rat limbic forebrain by amphetamine: role of its hydroxylated metabolites.

Authors:  P L Mobley; E Sanders-Bush; H E Smith; F Sulser
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-04       Impact factor: 3.000

3.  Structural and steric requirements for beta-phenethylamines as agonists of the noradrenergic cyclic AMP generating system in the rat limbic forebrain.

Authors:  S E Robinson; P L Mobley; H E Smith; F Sulser
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-06       Impact factor: 3.000

4.  The sensitivity of pineal gland beta-receptors appears to be dependent upon calcium ions.

Authors:  M Wilkinson
Journal:  Pflugers Arch       Date:  1978-02-22       Impact factor: 3.657

5.  A pharmacological study of changes in central nervous system receptor responsiveness after long-term dexamphetamine and apomorphine administration.

Authors:  R C Bailey; D M Jackson
Journal:  Psychopharmacology (Berl)       Date:  1978-04-11       Impact factor: 4.530

Review 6.  Putative mechanisms of action of antidepressant drugs in affective and anxiety disorders and pain.

Authors:  P Blier; F V Abbott
Journal:  J Psychiatry Neurosci       Date:  2001-01       Impact factor: 6.186

7.  Up- and down- regulation of central postsynaptic alpha 2 receptors reflected in the growth hormone response to clonidine in reserpine-pretreated rats.

Authors:  E Eriksson; S Edén; K Modigh
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

8.  Development of and recovery from subsensitivity of the noradrenergic cyclic AMP generating system in brain. Effect of amphetamine following inhibition of its aromatic hydroxylation by iprindole.

Authors:  D H Manier; D D Gillespie; F Sulser
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-08       Impact factor: 3.000

9.  Subsensitivity of human beta-adrenergic adenylate cyclase after salbutamol treatment of depression.

Authors:  B Lerer; R P Ebstein; R H Belmaker
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.